Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
TMO US​

Thermo Fisher Scientific Inc.(TMO US)

$673.82-2.720.40%Ext:$680.69+6.871.02%(Market Closed · 23:48:54 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Thermo Fisher Scientific Inc. — Company Profile

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Sector
Energy
Industry
Oil, Gas & Consumable Fuels
Exchange
UN
CEO
Marc N. Casper
Headquarters
Waltham, MA, US
IPO Date
Mar 17, 1980
Employees
125,000
Website
www.thermofisher.com

Key Metrics

Price
$654.80
Market Cap
$242.11B
Revenue (TTM)
$11.01B
Net Income (TTM)
$1.65B
EPS (TTM)
4.44
P/E (TTM)
35.30
P/B (TTM)
4.66
Dividend Yield
36.55%
ROE (TTM)
3.18%
ROA (TTM)
1.46%
Operating Margin
16.93%
Beta
0.50

Dividends

Last Dividend
$0.47
Last Yield
0.37%

Summary

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Website
www.thermofisher.com
Location
Waltham, MA, US
Phone781 622 1000
Employees125,000
CEOMarc N. Casper
Sector
Energy
Industry
Oil, Gas & Consumable Fuels
IPO DateMar 17, 1980

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(3.3K)

Expand
  • 8-KResults of Operations and Financial Condition21 Oct
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership29 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 144Pettiti Gianluca31 Aug
  • 4Statement of changes in beneficial ownership26 Aug
  • 144CASPER MARC N24 Aug
  • 4Statement of changes in beneficial ownership24 Aug
  • 4Statement of changes in beneficial ownership24 Aug
  • 144CASPER MARC N21 Aug
  • 144CASPER MARC N20 Aug

News

  • Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More23 Oct
  • Thermo Fisher: You Don't Need A Microscope To See The Growth Anymore21 Oct
  • Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors21 Oct
  • Thermo Fisher Stocks Rise 1.0% as Revenue Growth Beats Estimates21 Oct
  • Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings21 Oct
  • Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript21 Oct
  • TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market21 Oct
  • Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics21 Oct
  • Thermo Fisher Q3: The Recovery Is Real, And I'm Still Buying21 Oct
  • Thermo Fisher Scientific Q3 Earnings Call Highlights21 Oct
  • Thermo Fisher posts higher third-quarter revenue and earnings as margins improve21 Oct
  • Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates21 Oct
  • Thermo Fisher Scientific Reports Third Quarter 2026 Results21 Oct
  • Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again20 Oct
  • Top Wall Street Forecasters Revamp Thermo Fisher Scientific Expectations Ahead Of Q3 Earnings20 Oct
  • Two stocks poised to benefit from rotation out of AI19 Oct
  • TMO DCF Analysis: Intrinsic Value $421 vs Price $69019 Oct
  • Banque Pictet & Cie SA Sells 6,618 Shares of Thermo Fisher Scientific Inc. $TMO17 Oct
  • What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings16 Oct
  • Pfizer, Thermo Fisher Scientific And More: CNBC's ‘Final Trades'15 Oct

Mentions in Filings

  • … and ensured timely program completion. Mr. Badugu brings to Astrotech extensive experience from the chemical manufacturing and consulting industries. Prior to Astrotech, he held the role of NPI Program Manager at <strong>Thermo Fisher Scientific</strong>, from 2020 to 2023, where he led the launch of COVID-19 diagnostic products. Mr. Badugu also held the role of Senior Program Manager at PVA Consulting Group, from 2017 to 2020. --- **SECURITY OWNERSHIP OF DIREC …
    ASTROTECH CorpThermo Fisher Scientific Inc.·DEF 14A - Definitive proxy statement·Q2 27·23 Oct
  • … hat the future of enterprise software will be agentic applications that are net-beneficiaries of AI transformation, and we focus on building, acquiring, and investing in those and related businesses. We have over 150,000 customers including Amazon, Dell, Salesforce, Aflac, <strong>Thermo Fisher Scientific</strong>, RBC Wealth Management, and Fitch Group. Learn more at www.parabolic.io. For investors, please visit ir.banzai.io. --- **Forward-Looking Statements**
    Banzai International, Inc.Thermo Fisher Scientific Inc.·EX-99.1 - 8-K - Material Modifications to Rights of Security Holders·Q4 26·22 Oct
  • … ration, a publicly traded manufacturer of analytical instruments, including Chairman of the board of directors, President, and Chief Executive Officer, and he served on the board of directors until its sale to <strong>Thermo Fisher Scientific Inc.</strong> in May 2011. From July 2012 to December 2015, Mr. Bowman served on the board of directors of Altera Corporation, a publicly traded programmable logic devices company. Mr. Bowman holds a B.S. in Physics from Bri …
    Personalis, Inc.Thermo Fisher Scientific Inc.·DEFM14A - Definitive proxy statement (merger)·Q4 26·21 Oct
  • Mr. Goodman was appointed as a director of the Company on June 16, 2025. Mr. Goodman served as Chief Commercial Officer from November 2025 until March 27, 2026, when he was appointed to serve as Chief Executive Officer. He brings over 30 years of experience in sales strategy, go-to-market execution, strategic partnerships and growth management. He has been instrumental in shaping the Company’s recent commercial approach and is widely recognized f …
    Beyond Air, Inc.Thermo Fisher Scientific Inc.·PRE 14A - Preliminary proxy statement·Q3 27·20 Oct
  • … n-year tenure. In 1998, he was named President, then Chief Executive Officer in February 1999 and led its initial public offering in 2000. From 1994 to 2008, Dr. Short also served as a director of Invitrogen (now <strong>Thermo Fisher Scientific</strong>). From its founding until 1994, Dr. Short served as President of Stratacyte Corporation, an antibody engineering company and subsidiary of Stratagene Cloning Systems, Inc. (now Agilent Technologies, Inc.), a biot …
    BioAtla, Inc.Thermo Fisher Scientific Inc.·S-1 - Registration statement (general form)·Q4 26·19 Oct
  • … tnerships, alliance management, mergers and acquisitions, and the company’s equity investing portfolio. Previously, Ms. Mily served as Managing Director of Barclays plc from 2010 to 2020, Senior Vice President of <strong>Thermo Fisher Scientific</strong> from 2009 to 2010, and Managing Director, Senior Coverage Officer - Healthcare Investment Banking of Goldman Sachs Group, Inc. from 1993 to 2009. Ms. Mily currently serves on the boards of directors of Solventum …
    Rallybio CorpThermo Fisher Scientific Inc.·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·15 Oct

Key Stats

Trading

Px/Chg 1D$654.80 / +0.35%
Avg Volume2.20M
Beta0.50
Mkt Cap242.11B
FD Mkt Cap228.12B

Float

Shrs Out/Float369.75M / 368.82M
Short Float0.01%
Days to Cover2.19
Stock Repurchased$3.00B

Current Valuation

EV282.14B
EV/EBITDA25.28
EV/Sales6.24
P/B4.66
P/S5.36
FCF Yield0.34%
ROE3.18%
ROA1.46%
Current Ratio1.53

Dividend

Cash$0.47
Yield36.55%
Yield (TTM)36.55%

Estimates

P/E35.30
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24May '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings66.1430.7836.7825.3291.18146.64
Price / Sales10.084.765.153.7414.7422.00
Price / Book Value4.174.864.723.233.374.66
Price / Free Cash Flow88.3530.9531.8322.0760.19296.70
ENTERPRISE VALUE METRICS
Enterprise Value234,631.2241,609.9248,950.5189,241.0211,216.0282,138.5
Enterprise Value / Sales11.715.385.814.4117.2925.64
Enterprise Value / EBITDA49.2720.2322.2416.0465.70122.14
Enterprise Value / EBIT63.3828.2231.9621.7784.89150.07

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue3.2%39,211.044,915.042,857.042,879.044,556.0
Gross Income-3.9%19,634.019,011.017,194.017,728.016,778.0
EBITDA-1.1%11,969.011,942.011,195.011,800.011,466.0
EBIT-1.9%9,377.08,561.07,789.08,692.08,686.0
Net Income-3.4%7,725.06,950.05,995.06,335.06,737.0
EPS (Diluted)-2.3%19.4617.6415.4516.5317.74
BALANCE SHEET
Cash & ST Inv22.6%4,477.08,524.08,083.05,580.010,110.0
Total Assets3.8%95,123.097,154.098,726.097,321.0110,343.0
Total Liabilities1.2%54,146.053,006.051,884.047,650.056,807.0
Total Shareholder Equity7%40,793.043,978.046,735.049,584.053,407.0
CASH FLOW
Net Operating Cash Flow-4.9%9,543.09,154.08,406.08,667.07,818.0
Cap Ex-11.8%-2,523.0-2,243.0-1,479.0-1,400.0-1,525.0
Free Cash Flow-2.7%7,020.06,911.06,927.07,267.06,293.0

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)673.32
Basic Shares369.75
Market Cap248,958.2
Diluted Shares371.00
Fully Diluted Shares Outstanding371.00
Fully Diluted Market Cap249,801.7
+Consolidated Debt41,370.0
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-5,461.0
−Short-term Investments-600.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest128.0
+Pension Liabilities—
Enterprise Value284,995.2

Segment data

Revenue

by Products and services

  • Consumables42%
  • Service42%
  • Instruments16%

Revenue

by Geography

  • United States52%
  • Europe27%
  • Asia Pacific18%
  • All Other Countries4%

Related companies

ITOCHU Corporation

ITOCY US

Midea Group Co., Ltd.

000333 CS

Slb Limited/nv

SLB US

Sumitomo Corporation

SSUMY US

Rockwell Automation, Inc

ROK US

Marubeni Corporation

MARUY US

Poste Italiane S.p.A.

PITAF US

CK Hutchison Holdings Limited/ADR

CKHUY US

Guangdong Songfa Ceramics Co.,Ltd.

603268 CG

Gree Electric Appliances, Inc. of Zhuhai

000651 CS

Pembina Pipeline Corp

PBA US

Halliburton Co

HAL US